MK-8722, a broad-spectrum AMPK activator, demonstrates potent metabolic benefits but also induces reversible cardiac hypertrophy (48), likely due to non-selective activation of AMPKγ2, a subunit linked to hypertrophic signaling. The gene discussed is PRKAA1; the disease is cardiac hypertrophy.